Literature DB >> 17350951

Future issues in highly conformal radiotherapy for head and neck cancer.

Mary Feng1, Avraham Eisbruch.   

Abstract

Improving the conformity of the radiation dose to targets in the head and neck promises reduced toxicity and, in some cases, potentially improved local-regional tumor control. Intensity-modulated radiotherapy (IMRT) is a method that allows highly conformal delivery of radiotherapy. In recent years, its use has spread rapidly in both academic and community radiation oncology facilities. The use of IMRT has raised multiple issues related to target definition, optimal treatment delivery methods, and the need to account for anatomic changes occurring during therapy. Some of these issues are reviewed in this article.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17350951     DOI: 10.1200/JCO.2006.10.4638

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  6 in total

1.  Co-registration of cone beam CT and planning CT in head and neck IMRT dose estimation: a feasible adaptive radiotherapy strategy.

Authors:  C Yip; C Thomas; A Michaelidou; D James; R Lynn; M Lei; T Guerrero Urbano
Journal:  Br J Radiol       Date:  2013-11-28       Impact factor: 3.039

2.  Brachial plexopathy after chemoradiotherapy for head and neck squamous cell carcinoma.

Authors:  Nele Platteaux; Piet Dirix; Robert Hermans; Sandra Nuyts
Journal:  Strahlenther Onkol       Date:  2010-08-30       Impact factor: 3.621

3.  Radiomics in Head and Neck Cancers Radiotherapy. Promises and Challenges.

Authors:  Roxana Irina Iancu; A D Zara; C C Mirestean; D P T Iancu
Journal:  Maedica (Bucur)       Date:  2021-09

4.  Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck.

Authors:  Daniel A Hamstra; Kuei C Lee; Bradford A Moffat; Thomas L Chenevert; Alnawaz Rehemtulla; Brian D Ross
Journal:  Transl Oncol       Date:  2008-12       Impact factor: 4.243

5.  Low frequency of HER2 amplification and overexpression in early onset gastric cancer.

Authors:  Cathy B Moelans; Anya N Milne; Folkert H Morsink; G Johan A Offerhaus; Paul J van Diest
Journal:  Cell Oncol (Dordr)       Date:  2011-03-11       Impact factor: 6.730

Review 6.  Advances in the management of squamous cell carcinoma of the head and neck.

Authors:  Jean-Pascal Machiels; Maarten Lambrecht; François-Xavier Hanin; Thierry Duprez; Vincent Gregoire; Sandra Schmitz; Marc Hamoir
Journal:  F1000Prime Rep       Date:  2014-06-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.